| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
42,617 |
37,597 |
$4.54M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
27,414 |
23,809 |
$4.50M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
56,105 |
50,168 |
$4.10M |
| 80050 |
General health panel |
16,157 |
14,488 |
$582K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
19,257 |
16,825 |
$567K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
34,077 |
27,805 |
$494K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12,009 |
10,739 |
$481K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
22,529 |
18,125 |
$449K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
8,715 |
5,719 |
$366K |
| 71046 |
Radiologic examination, chest; 2 views |
20,521 |
18,175 |
$364K |
| 80053 |
Comprehensive metabolic panel |
53,932 |
45,273 |
$331K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
20,443 |
17,557 |
$312K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
15,626 |
11,036 |
$301K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
56,095 |
47,199 |
$261K |
| 87430 |
|
15,677 |
14,152 |
$210K |
| 87400 |
|
33,847 |
18,190 |
$173K |
| 36415 |
Collection of venous blood by venipuncture |
87,019 |
70,106 |
$171K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
604 |
424 |
$132K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,778 |
2,088 |
$125K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,801 |
2,596 |
$118K |
| 81025 |
|
17,646 |
15,597 |
$113K |
| 87070 |
|
13,996 |
12,569 |
$101K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
870 |
336 |
$98K |
| 81001 |
|
48,305 |
40,983 |
$93K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
19,159 |
16,768 |
$78K |
| 70450 |
Computed tomography, head or brain; without contrast material |
652 |
572 |
$77K |
| 80061 |
Lipid panel |
7,096 |
6,379 |
$76K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
333 |
197 |
$73K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
162 |
151 |
$62K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,011 |
2,665 |
$60K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
954 |
837 |
$60K |
| 87088 |
|
9,662 |
8,533 |
$58K |
| 84484 |
|
8,950 |
7,424 |
$57K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,568 |
2,296 |
$53K |
| G0378 |
Hospital observation service, per hour |
969 |
811 |
$49K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,316 |
2,903 |
$41K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,361 |
1,215 |
$40K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,358 |
1,215 |
$40K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,121 |
993 |
$33K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
13,603 |
11,300 |
$32K |
| 83690 |
|
6,751 |
5,968 |
$32K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
932 |
805 |
$29K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
995 |
899 |
$29K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,105 |
619 |
$26K |
| 86780 |
|
1,914 |
1,724 |
$22K |
| 83721 |
|
4,263 |
3,638 |
$22K |
| 96417 |
|
1,045 |
644 |
$21K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,173 |
1,121 |
$20K |
| 71045 |
Radiologic examination, chest; single view |
1,040 |
916 |
$19K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,415 |
2,191 |
$19K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
897 |
680 |
$16K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
114 |
68 |
$16K |
| 96523 |
|
963 |
788 |
$16K |
| J7050 |
Infusion, normal saline solution, 250 cc |
4,615 |
2,118 |
$13K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
196 |
171 |
$13K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
352 |
104 |
$12K |
| 87420 |
|
895 |
819 |
$11K |
| 74019 |
|
361 |
329 |
$10K |
| 83970 |
|
420 |
378 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
746 |
613 |
$10K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
29 |
26 |
$9K |
| 83735 |
|
2,398 |
1,627 |
$9K |
| 84439 |
|
1,076 |
970 |
$8K |
| 83880 |
|
374 |
339 |
$8K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,534 |
2,640 |
$7K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
15 |
14 |
$7K |
| 82550 |
|
1,713 |
1,495 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,563 |
7,313 |
$6K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
362 |
271 |
$6K |
| 85027 |
|
1,465 |
1,290 |
$6K |
| 82553 |
|
950 |
824 |
$5K |
| 82728 |
|
540 |
477 |
$5K |
| 80069 |
|
1,029 |
839 |
$5K |
| 82533 |
|
324 |
265 |
$4K |
| C1769 |
Guide wire |
76 |
64 |
$4K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
17 |
13 |
$4K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
716 |
597 |
$4K |
| 96415 |
|
189 |
125 |
$4K |
| 80320 |
|
1,271 |
928 |
$3K |
| 82570 |
|
1,117 |
972 |
$3K |
| 84100 |
|
1,116 |
631 |
$3K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
516 |
451 |
$3K |
| 86850 |
|
652 |
561 |
$3K |
| 95811 |
|
30 |
26 |
$3K |
| 82746 |
|
253 |
227 |
$2K |
| 82378 |
|
238 |
156 |
$2K |
| 83615 |
|
694 |
531 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,108 |
1,336 |
$2K |
| 84156 |
|
1,136 |
985 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
491 |
421 |
$2K |
| 87077 |
|
398 |
333 |
$2K |
| 71250 |
|
12 |
12 |
$2K |
| 87186 |
|
394 |
329 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
25 |
25 |
$2K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
14 |
12 |
$2K |
| 86803 |
|
130 |
117 |
$2K |
| 86900 |
|
648 |
565 |
$2K |
| 85045 |
|
567 |
480 |
$2K |
| 83550 |
|
260 |
232 |
$1K |
| 72100 |
|
92 |
68 |
$1K |
| 82607 |
|
128 |
115 |
$1K |
| 83540 |
|
287 |
257 |
$1K |
| 86901 |
|
655 |
565 |
$1K |
| 86592 |
|
309 |
271 |
$1K |
| 87340 |
|
126 |
117 |
$1K |
| 86762 |
|
73 |
67 |
$892.18 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
335 |
299 |
$810.36 |
| 73562 |
|
41 |
39 |
$738.24 |
| 81003 |
|
212 |
190 |
$716.21 |
| 86787 |
|
63 |
54 |
$660.59 |
| 73610 |
|
25 |
25 |
$648.10 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
211 |
194 |
$624.42 |
| 73630 |
|
38 |
37 |
$601.55 |
| 86140 |
|
148 |
128 |
$559.44 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,739 |
1,338 |
$530.22 |
| 90715 |
|
27 |
24 |
$492.55 |
| 85660 |
|
102 |
91 |
$479.37 |
| 82043 |
|
138 |
134 |
$445.06 |
| 73130 |
|
14 |
12 |
$437.03 |
| 85651 |
|
142 |
132 |
$435.18 |
| 85730 |
|
142 |
128 |
$414.27 |
| 82962 |
|
171 |
149 |
$393.89 |
| 85610 |
|
193 |
171 |
$390.34 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,736 |
1,351 |
$320.06 |
| 82040 |
|
149 |
136 |
$311.87 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
223 |
187 |
$305.36 |
| 87449 |
|
33 |
26 |
$287.52 |
| 73030 |
|
36 |
25 |
$275.10 |
| 80055 |
|
12 |
12 |
$255.14 |
| 85379 |
|
45 |
38 |
$244.32 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,593 |
1,326 |
$243.15 |
| J1790 |
Injection, droperidol, up to 5 mg |
58 |
31 |
$224.33 |
| 82950 |
|
56 |
49 |
$215.83 |
| 84704 |
|
18 |
14 |
$183.48 |
| 74018 |
|
12 |
12 |
$156.48 |
| 87631 |
|
832 |
679 |
$142.63 |
| 87040 |
|
14 |
12 |
$134.16 |
| 96376 |
|
17 |
14 |
$131.84 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
58 |
52 |
$128.98 |
| 90686 |
|
15 |
14 |
$126.42 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
70 |
51 |
$67.93 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
47 |
27 |
$60.16 |
| 84550 |
|
19 |
13 |
$54.24 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
255 |
222 |
$50.40 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
101 |
94 |
$50.12 |
| 87075 |
|
16 |
15 |
$37.88 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
130 |
95 |
$32.10 |
| J2060 |
Injection, lorazepam, 2 mg |
13 |
12 |
$26.52 |
| 85347 |
|
14 |
12 |
$21.00 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,623 |
150 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
281 |
230 |
$0.00 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
469 |
413 |
$0.00 |
| G0177 |
Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) |
868 |
66 |
$0.00 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
247 |
184 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
73 |
58 |
$0.00 |
| 81002 |
|
14 |
14 |
$0.00 |
| 00126 |
|
148 |
118 |
$0.00 |
| G0410 |
Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes |
752 |
54 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
172 |
154 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
14 |
14 |
$0.00 |